UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 46

Sortiert nach

Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

Critical care (London, England), 2020-12, Vol.24 (1), p.676-676, Article 676

2020

Link zum Volltext

Verfügbarkeit prüfen

Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19

Scientific reports, 2021-06, Vol.11 (1), p.13325-10, Article 13325

2021

Link zum Volltext

Verfügbarkeit prüfen

Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observational Study

Annals of surgical oncology, 2022-01, Vol.29 (1), p.152-162

2022

Link zum Volltext

Verfügbarkeit prüfen

Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study

Frontiers in oncology, 2021-07, Vol.11, p.670396-670396

2021

Link zum Volltext

Verfügbarkeit prüfen

ASO Visual Abstract: Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin—A Single Center Observational Study

Annals of surgical oncology, 2021-12, Vol.28 (Suppl 3), p.698-699

2021

Link zum Volltext

Verfügbarkeit prüfen

Nachwuchsförderung in der AIO: die Young Medical Oncologists

Forum (Heidelberg), 2023-06, Vol.38 (3), p.190-192

2023

Link zum Volltext

Verfügbarkeit prüfen

Perioperative Therapie des CRC

InFo Hämatologie + Onkologie, 2020-03, Vol.23 (3), p.10-14

2020

Link zum Volltext

Verfügbarkeit prüfen

Efficacy, Molecular Biology, Quality of Life, or Economic Aspects: What Do We Really FOCUS oN?

Journal of clinical oncology, 2022-04, Vol.40 (11), p.1260-1262

2022

Link zum Volltext

Verfügbarkeit prüfen

AIO-FIRE-8-Studie (AIO‑KRK/YMO‑0519): Erstlinientherapie mit Trifluridin/Tipiracil (TAS-102) und dem EGFR-Antikörper Panitumumab oder dem VEGF-Inhibitor Bevacizumab bei metastasiertem kolorektalem Karzinom mit Kontraindikation gegen eine Kombinationschemotherapie: eine prospektive, randomisierte, multizentrische Phase-II-Studie

Forum (Heidelberg), 2021-06, Vol.36 (3), p.251-252

2021

Link zum Volltext

Verfügbarkeit prüfen

Systemische Therapie des metastasierten Kolonkarzinoms

Onkologie (Heidelberg, Germany), 2021-03, Vol.27 (3), p.259-266

2021

Link zum Volltext

Verfügbarkeit prüfen

Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212)

Clinical cancer research, 2024-04, Vol.30 (7), p.1256

2024

Link zum Volltext

Verfügbarkeit prüfen

Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials

European journal of cancer (1990), 2023-09, Vol.190, p.112945-112945, Article 112945

2023

Link zum Volltext

Verfügbarkeit prüfen

Impact of number and size of colorectal metastases (CRM) on survival in patients with RAS wild-type metastatic colorectal cancer treated within the PanaMa trial (AIO KRK 0212)

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.3551-3551

2023

Link zum Volltext

Verfügbarkeit prüfen

Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic CRC: Analysis of patients treated within the PanaMa trial (AIO KRK 0212)

Journal of clinical oncology, 2023-02, Vol.41 (4_suppl), p.127-127

2023

Link zum Volltext

Verfügbarkeit prüfen

Sequential therapy of refractory metastatic pancreatic cancer with 5-FU/LV/irinotecan (FOLFIRI) vs. 5-FU/LV/oxaliplatin (OFF). The PANTHEON trial (AIO PAK 0116)

Journal of cancer research and clinical oncology, 2024-07, Vol.150 (7), p.332, Article 332

2024

Link zum Volltext

Verfügbarkeit prüfen

Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma – A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials

European journal of cancer (1990), 2021-06, Vol.150, p.250-259

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 46

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(45)
Dissertationen
(1)

Sprache

Englisch
(40)
Deutsch
(6)

Erscheinungsjahr

n.n

Thema

Oncology
(23)
Science & Technology
(21)
Life Sciences & Biomedicine
(19)
Humans
(13)
Metastases
(9)
Metastatic Colorectal Cancer
(9)
Colorectal Cancer
(8)
Metastasis
(8)
Cancer
(7)
Colorectal Carcinoma
(7)
Patients
(7)
Survival
(7)
Tumors
(7)
Chemotherapy
(6)
Colorectal Neoplasms - Pathology
(6)
Medicine
(6)
Medicine & Public Health
(6)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(5)
Colorectal Neoplasms - Drug Therapy
(5)
Female
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Thromboembolic complications in critically ill COVID-19 patients are associated with impaired fibrinolysis

Viscoelastic testing reveals normalization of the coagulation profile 12 weeks after severe COVID-19

Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin: A Single-Center Observational Study

Mucin-1 Protein Is a Prognostic Marker for Pancreatic Ductal Adenocarcinoma: Results From the CONKO-001 Study

ASO Visual Abstract: Sodium Thiosulfate Reduces Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy with Cisplatin—A Single Center Observational Study

FIRE-9 - PORT / AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer

Pembrolizumab and trastuzumab in combination with FLOT in the perioperative treatment of HER2-positive, localized esophagogastric adenocarcinoma—a phase II trial of the AIO study group (AIO STO 0321)

Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy-Analysis of the Phase 3 XELAVIRI Trial

Nachwuchsförderung in der AIO: die Young Medical Oncologists

Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb Efficacy

Perioperative Therapie des CRC

Efficacy, Molecular Biology, Quality of Life, or Economic Aspects: What Do We Really FOCUS oN?

Systemische Therapie des metastasierten Kolonkarzinoms

Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212)

Negative Hyperselection of Resistance Mutations for Panitumumab Maintenance in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa Phase II Trial, AIO KRK 0212)

Optimal maintenance strategy following FOLFOX plus anti-EGFR induction therapy in patients with RAS wild type metastatic colorectal cancer: An individual patient data pooled analysis of randomised clinical trials

Consensus Molecular Subtypes as Biomarkers of Fluorouracil and Folinic Acid Maintenance Therapy With or Without Panitumumab in RAS Wild-Type Metastatic Colorectal Cancer (PanaMa, AIO KRK 0212)

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial

Size-related heterogeneity of colorectal liver metastases (CRLM) in patients with advanced RAS wild-type metastatic colorectal cancer (mCRC) treated in the PanaMa trial: Implication for treatment decisions

Impact of number and size of colorectal metastases (CRM) on survival in patients with RAS wild-type metastatic colorectal cancer treated within the PanaMa trial (AIO KRK 0212)

Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: An analysis of the Panama trial (AIO KRK0212)

Prognostic and predictive impact of metastatic organ involvement on maintenance therapy in advanced metastatic CRC: Analysis of patients treated within the PanaMa trial (AIO KRK 0212)

Sequential therapy of refractory metastatic pancreatic cancer with 5-FU/LV/irinotecan (FOLFIRI) vs. 5-FU/LV/oxaliplatin (OFF). The PANTHEON trial (AIO PAK 0116)

Impact of completeness of adjuvant gemcitabine, relapse pattern, and subsequent therapy on outcome of patients with resected pancreatic ductal adenocarcinoma – A pooled analysis of CONKO-001, CONKO-005, and CONKO-006 trials

Suchergebnisse filtern